rs2227692
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000602.5(SERPINE1):c.1087+162C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 152,226 control chromosomes in the GnomAD database, including 2,083 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 2083 hom., cov: 32)
Consequence
SERPINE1
NM_000602.5 intron
NM_000602.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.62
Publications
21 publications found
Genes affected
SERPINE1 (HGNC:8583): (serpin family E member 1) This gene encodes a member of the serine proteinase inhibitor (serpin) superfamily. This member is the principal inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. The protein also functions as a component of innate antiviral immunity. Defects in this gene are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency), and high concentrations of the gene product are associated with thrombophilia. [provided by RefSeq, Aug 2020]
SERPINE1 Gene-Disease associations (from GenCC):
- congenital plasminogen activator inhibitor type 1 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINE1 | NM_000602.5 | c.1087+162C>T | intron_variant | Intron 7 of 8 | ENST00000223095.5 | NP_000593.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.138 AC: 20929AN: 152106Hom.: 2074 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
20929
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.138 AC: 20961AN: 152226Hom.: 2083 Cov.: 32 AF XY: 0.146 AC XY: 10886AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
20961
AN:
152226
Hom.:
Cov.:
32
AF XY:
AC XY:
10886
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
6056
AN:
41530
American (AMR)
AF:
AC:
4757
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
448
AN:
3470
East Asian (EAS)
AF:
AC:
1789
AN:
5176
South Asian (SAS)
AF:
AC:
1045
AN:
4830
European-Finnish (FIN)
AF:
AC:
1097
AN:
10608
Middle Eastern (MID)
AF:
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5355
AN:
68006
Other (OTH)
AF:
AC:
343
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
888
1777
2665
3554
4442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1033
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.